The US Food and Drug Administration (FDA) has approved the Vivace microneedling with radio frequency device to help tighten skin after a trial conducted by Farhan Taghizadeh at New Mexico Facial Plastics (NMFP)
Vivace microneedling with radio frequency involves the placement of a handheld device over the area of skin to be treated, which activates the radio frequency energy.
The handpiece consists of a multiple needle head that is targeted to a specified depth depending on each patient's desired result.
When these tiny needles puncture the skin, they produce very tiny "wounds" that stimulate new collagen formation in the skin, as well as the production of hyaluronic acid and elastin, both skin-tightening agents.
Taghizadeh said: "Vivace combines targeted micro-needling with radio-frequency energy to help stimulate and tighten the skin even in the deepest layers.
“Vivace microneedling can be used on almost any area of the face or body and any skin type and is especially helpful in reducing acne scarring."
The benefits of Vivace microneedling include smaller pore size, reduced secretion of skin oils (seborrhea), minimised appearance of fine lines and wrinkles, improved delivery and absorption of medical-grade skin care products and reduced occurrence of acne, according to NMFP.